355.36
+3.06
+(0.87%)
As of 10:52:11 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,136,600.00
978,000.00
802,500.00
598,200.00
755,700.00
Investing Cash Flow
582,500.00
-719,600.00
-811,500.00
-486,900.00
-738,500.00
Financing Cash Flow
-1,272,900.00
-11,900.00
75,400.00
44,800.00
-16,900.00
End Cash Position
1,553,900.00
1,207,700.00
961,200.00
894,800.00
738,700.00
Income Tax Paid Supplemental Data
385,900.00
332,500.00
275,700.00
153,300.00
92,800.00
Interest Paid Supplemental Data
47,200.00
56,000.00
29,100.00
16,200.00
20,700.00
Capital Expenditure
-238,500.00
-230,400.00
-138,800.00
-120,800.00
-59,300.00
Issuance of Debt
--
--
800,000.00
--
--
Repayment of Debt
-400,000.00
-100,000.00
-800,000.00
--
-50,000.00
Repurchase of Capital Stock
-1,012,000.00
-13,800.00
-11,400.00
-10,800.00
-3,700.00
Free Cash Flow
898,100.00
747,600.00
663,700.00
477,400.00
696,400.00
12/31/2020 - 6/17/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LQDA Liquidia Corporation
14.60
+1.32%
MNKD MannKind Corporation
5.84
-2.18%
ARGX argenx SE
666.17
+0.07%
HALO Halozyme Therapeutics, Inc.
56.72
+0.53%
CORT Corcept Therapeutics Incorporated
68.36
-2.20%
INSM Insmed Incorporated
77.01
+0.94%
ALNY Alnylam Pharmaceuticals, Inc.
276.28
-0.32%
JAZZ Jazz Pharmaceuticals plc
125.43
+0.30%
GMAB Genmab A/S
19.83
+0.08%
REGN Regeneron Pharmaceuticals, Inc.
682.54
-0.08%